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[Abstract] Tumour microenvironment and cancer-associated fibroblasts in particular exhibit 
tumour promoting abilities that are not present in their normal counterparts (Calvo et al., 2013;  
Hanahan  and Coussens,   2012). Therefore, functional and molecular characterization of the 
modifications occurring in fibroblasts during tumour progression is essential to fully understand 
their role in tumour progression. Previous studies have addressed this issue using human 
fibroblasts and comparing normal and adjacent fibroblasts to tumour-associated fibroblasts 
(Kalluri and Zeisberg, 2006). However, these studies are hampered by the intrinsic variability of 
human samples (e.g. pairing, age, genomic landscape, etc). In order to overcome these issues, 
we used a fully characterised mouse breast cancer model, MMTV-PyMT (Guy et al., 1992; Lin et 
al., 2003). MMTV-PyMT transgenic mice express the Polyoma Virus middle T antigen under the 
direction of the mouse mammary tumor virus promoter/enhancer. This is a multifocal luminal 
breast cancer model that goes through well defined and characterised stages (namely, 
hyperplasia, adenoma, carcinoma and invasive carcinoma). Interestingly, this model has a 100% 
incidence, is very desmoplastic (presenting high concentration of fibroblasts) and gives raise to 
spontaneous metastasis in the lung with 80-94% incidence. Importantly, at least for the inguinal 
mammary glands (glands 4 and 9), the different tumoral stages are well correlated to the age of 
the mouse: hyperplasia arising at 6 weeks of age, adenoma between 6-8 weeks of age, 
carcinoma and invasive carcinoma from 8 weeks onwards. This model allowed us to confidently 
isolate fibroblasts from different tumoral stages and carefully characterise their functional and 
molecular properties (Calvo et al., 2013).  
 
Materials and Reagents 
 
1. FVB/n MMTV-PyMT females between 4 and 14 weeks of age and MMTV-PyMT negative 
siblings for isolation of normal mammary gland fibroblasts (NFs) (The Jackson Laboratory, 
catalog number: 002374)  
2. Phoenix-Eco packing cells (ATCC, catalog number: CRL-3214) (read Note 6 for more 
information) 
3. pBabe-HPV-E6-puromycin plasmid (or immortalization plasmid of choice, see Note 6) 
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Note: This was generated in our laboratory but there are alternatives available (pLenti-
puro-HPV-16 E6/E7; Applied Biological Materials, catalog number: G268). 
4. Dulbecco’s Modified Eagle’s Medium (DMEM) (high glucose with stable L-glutamine) (Life 
Technologies, Gibco
®
, catalog number: 41966-029) 
5. 50x Sodium Butyrate (500 mM) 
6. Polybrene
®
 (1,5-dimethyl-1,5-diazaundecamethylene polymethobromide, hexadimethrine 
bromide) (Sigma-Aldrich, catalog number: AL-118) (1000x solution at 2 mg/ml) 
7. Insulin-Transferrin-Selenium (ITS) solution (Life Technologies, catalog number: 51300-
044). 
8. Calcium phosphate Transfection Kit (ProFection
®
 Mammalian Transfection System) 
(Promega Corporation, catalog number: E1200)  
9. Fetal Bovine Serum (FBS)  
10. Phosphate-buffered saline (PBS) 
11. PBS without Ca
2+
 and Mg
2+
  
12. Penicillin/Streptomycin 
13. EDTA (1 mM in PBS without Ca
2+
 and Mg
2+
). 
14. 10% Formalin solution, neutral-buffered (10% NBF) 
15. 100x Collagenase/dispase (100 mg/ml) (Roche Diagnostics, catalog number: 
11097113001) 
16. 1000x Puromycin (2 mg/ml) (Sigma-Aldrich, catalog number: P9620) 
17. 1000x DNase I (10 mg/ml) (Sigma-Aldrich, catalog number: D4513) 
18. Trypsin/EDTA 
19. Virkon (DuPont Rely+On Virkon, catalog number: 1235-8667) 
20. Complete media (see Recipes) 
 
Equipment 
 
1. 0.22 µm, 0.45 µm, 3 mm filters 
2. 20 mm coverslip  
3. Tissue culture plastic-ware 
4. 37 °C shaker 
5. Tissue culture laminar-flow hood 
6. 10 cm tissue culture dish 
7. Centrifuge  
8. 37 °C, 5% CO2, cell culture incubator  
9. Scalpels 
10. Surgical scissors 
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11. Dissecting instruments 
 
Procedure 
 
A. Before starting 
1. Please read Notes section for guidance.  
2. Obtain MMTV-PyMT positive females between 5 and 14 week of age.  
Note: Correlation between age and tumoral stage may vary in other tumor models. Read 
Notes section for more information. 
3. Make sure you have all the materials, reagents and equipment. 
 
B. Dissecting samples – tumor material 
4. Mammary tissue from the 4
th
 and 9
th
 inguinal glands is dissected using surgical 
instruments. Tissue is kept in ice-cold PBS until further use.  
Note: For normal mammary gland isolation, mammary tissue of MMTV-PyMT negative 
females of 10 weeks of age is dissected. For isolation of hyperplastic tumors, mammary 
tissue of MMTV-PyMT positive females of 6 weeks of age is dissected. For isolation of 
adenoma, carcinoma, and invasive carcinoma, mammary tissue of MMTV-PyMT positive 
females of 7, 8 and 10 weeks of age, respectively, is dissected (Figure 1). These time 
points may vary. For more information about the determination of the correct age and 
tumoural stage, please read Note 2 at the end of the protocol.  
5. Samples are moved into a laminar flow tissue culture hood under sterile conditions. 
6. Tissue samples are carefully analysed checking for signs indicative of their tumoral stage. 
As a rough guide, normal tissue appears fatty and soft. Hyperplastic tissue appears 
considerably enlarged but still fatty and soft. Adenoma, carcinoma, and invasive 
carcinoma appear enlarged, stiff and multimodular to variable degrees (Figure 1).   
7. Isolate single modules on each tumor (2-3 per tumour is recommended.) before 
proceeding to the next stage.  
Note: As a result of the multimodular aspect of this type of tumour, special care must be 
taken in order to use and analyse only single modules. This is highly important if you 
want to make sure that you are isolating cells from a specific stage as individual modules 
may have progressed to different tumoral stages. The size of the modules varies with 
tumour size, age, localization and between individual mice. Expert pathological advice is 
recommended (see Notes 2-3). 
8. For each single module, take one part for histopathology analysis and one part for 
isolation of fibroblasts. For histopathological analysis, the sample is fixed in 10% NBF 
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overnight at 4 °C. See Figure 1 for representative hematoxylin and eosin staining of 
tissues. 
Note: Histopathological analysis procedures will not be discussed here. Please refer to 
other protocols. 
9. For isolation of fibroblasts, the rest of the sample is transferred to a 10 cm tissue culture 
dish and processed into smaller pieces using a scalpel and/or surgical scissors.   
 
 
Figure 1. Representative tissue samples and hematoxylin and eosin staining of 
tissues from normal FVB/n mammary glands and progressive breast tumoural stages 
(hyperplasia, adenoma and carcinoma) from the MMTV-PyMT model. Scale bars 
represent 100 µm. 
 
C. Processing normal mammary tissue samples 
10. For normal mammary tissue, the smaller tissue pieces are placed into dishes where they 
are compressed under a 20 mm coverslip to prevent the fatty tissue floating.  
Note: If normal mammary tissue is processed using the collagenase/disparse approach 
(see below), very low numbers of fibroblasts are isolated.   
11. Fresh complete media DMEM is then added slowly to prevent samples from floating.  
Note: Samples need to be in contact with the plastic and the coverslip in order for the 
fibroblasts to come out of the sample. 
12. Media is replaced daily with fresh complete media for 7 days.  
Note: After 7 days, fibroblasts have come out of the tissue into the coverslip and the dish 
and can be transferred into a new dish.  
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13. Original tissue is removed. Coverslips are transferred to a new dish (side with cells facing 
up).   
14. The original dish and the dish with coverslips are washed once with PBS and fibroblasts 
trypsinized using Trypsin/EDTA for 10 min at 37 °C. 
15. Cells are resuspended and seeded into a new dish.  
Note: Cell numbers can be expanded minimally, always taking into account that primary 
cells enter senescence after prolonged culture in vitro.   
16. Cells are now ready for immortalization (starting at step 30). 
 
D. Processing mammary hyperplasia, adenoma and carcinoma tissue samples 
17. For hyperplasia, adenoma and carcinoma samples smaller tissue pieces are placed into 
dishes where they are further disgregatted using scalpels.  
Note: Alternatively, for extremely fatty hyperplasia samples normal tissue isolation 
approach (steps C10-16) can be used. 
18. Collagenase/dispase solution (100 mg/ml) is diluted 1:100 in sterile PBS Mg
2+
 Ca
2+
 free 
and filtered before use with 22 µm filter (final concentration 1 mg/ml). 
Note: Collagenase/dispase solution is a tissue dissociation solution that degredes 
collagen and reticular fibers without affecting the integrity of the plasma membrane. 
19. Disgregatted tissues are placed in a sterile tube with the appropriate amount of 
collagenase/dispase. Pipette up and down several times to help disaggregate. Samples 
are then incubated for 60 min at 37 °C and 180 rpm in an orbital shaker. 
Note: Generally use 2-3 ml per sample (250-500 mg of tissue). Adjust to sample size.  
20. One volume of PBS 1 mM EDTA is added to each sample. Pass it through the pipette 
several times. 
Note: EDTA stops the protease reaction as it is a collagenase inhibitor. 
21. Samples are filtered using the 3 mm filters.  
Note: This step removes undigested pieces of tissue. Alternative methods are also 
available (rubber syringe plunger, etc). 
22. Samples are centrifuged at 100 x g for 5 min at room temperature (RT).  
23. Supernatant is discarded. Pellet containing cells is washed with complete media and 
centrifuged at 100 x g for 5 min at RT again.  
24. Supernatant is discarded. Pellet containing cells is incubated for 10 min at RT with 
complete media plus DNase 1 (final concentration 10 µg/ml). 
Note: Often as a result of cell damage, DNA leaks into the dissociation medium 
increasing viscosity and causing handling problems. Purified DNase is included in cell 
isolation procedures to digest the nucleic acids without damaging the intact cells. 
25. Samples are centrifuged at 100 x g for 5 min at room temperature (RT).  
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26. Repeat step 23 twice. 
27. Media is removed and cells are resuspended in complete media and seeded in a dish. 
Place samples in the incubator. 
28. After 30 min, media in all samples is replaced with fresh complete media and place back 
in the incubator. 
Note: After 30 min, most of the fibroblasts would have adhered to the dish, whilst other 
cell types will remain in suspension. Using this tip will help you enrich for the fibroblastic 
population. 
29. After 2-3 days, isolated cells can be enriched for the fibroblastic population using the 
enhanced adherence to plastic of fibroblasts. 
a. Media is removed. 
b. Cells are washed with PBS once. 
c. Cells are covered with Trypsin/EDTA and placed in the incubator for 10 min.  
d. Cells are resuspended in complete media, seeded into a new dish and placed back in 
the incubator for 30 min. 
e. Media is replaced with fresh new complete media.  
 
E. Immortalizing primary fibroblasts from different tumoral stages 
30. Read Notes 4-5 before start. 
31. Growing Phoenix-ECO cells are seeded to reach 80% confluency by the time of 
transfection (see Note 6).  
Note: Phoenix-Eco cells are used to produce ecotropic viruses to infect mouse fibroblasts. 
To immortalize human fibroblasts, please use alternative approaches (see Notes 4 and 6). 
Optimization of volumes and titration of retroviruses is highly recommended but will not 
be discussed here. Using easy-to-spot positive controls (e.g. transfection of retroviral 
plasmids encoding fluorescent proteins) is also recommended. This allows for rapid 
evaluation of your infection efficiency (e.g. scoring for fluorescently positive cells). 
32. Once they reach 80% confluency, Phoenix-Eco cells are transfected using the calcium 
phosphate protocol. Usually for 10 cm plate. 
a. Replace media with complete media 2 h before transfection. 
b. In Tube A, mix pBabe-HPV-E6-puromycin (10 µg), CaCl2 2 M (67 µl) and Nuclease-
free water (up to 500 µl). 
c. In Tube B, add 500 µl of 2x Hepes. 
d. While bubbling the content in Tube A, slowly add content of Tube B into it. 
e. Leave 30 min at RT. 
f.    Add transfection mix dropwise into Phoenix-Eco cells. 
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33. After 18 h, in order to burst transcription, Sodium Butyrate is added to the cells (final 
concentration 10 mM).  
34. After 4 h, media is replaced with fresh complete media. 
35. After 48-72 h, media containing viruses is collected and filtered through a 0.45 µm filter. 
Virus can be aliquoted and stored at -80 °C until used.  
Note: All used material must be left o/n in virkon before disposal (see Note 5).  
36. Primary fibroblasts are infected with HPV-E6-puromycin retroviruses.  
a. Media on fibroblast cultures is removed. 
b. The virus-containing media is mixed 1:1 with complete fresh media and the resulting 
solution added to the fibroblasts.  
c. Polybrene (final concentration 2 µg/ml) is also added to your cells.  
Note: Infection efficiency may increase if receptor cells are in suspension (e.g. after 
trypsinization). Polybrene (hexadimethrine bromide) is a cationic polymer used to 
increase the efficiency of infection of certain cells with a retrovirus in cell culture. 
37. After 5 h, media is replaced with fresh media. 
Note: Alternatively, media can be replaced after 18 h. 
38. After 24-48 h, infected cells are selected by addition of puromycin (2 µg/ml final 
concentration) in the complete culture media. 
Note: Puromycin subsceptibility varies depending on the cell type. Final concentration 
needs to be optimized prior to final use. 
39. After 7-10 days, resistant clones expressing HPV-E6 (i.e. immortalized cell lines) are 
visible. Clones or pools can be expanded in culture of frozen down for subsequent use.  
Note: Eventually, characterization of the nature of the isolated and immortalized 
populations must be performed. This can be performed by analysis of expression of 
certain markers by immunofluorescence, FACS, etc. Recommended fibroblast markers 
are CD140A/PDGFRA, CD90/Thy-1, Vimentin, and Fibronectin. Fibroblasts should also 
be negative for immune cell markers (CD45 negative), endothelial markers (CD31 
negative) and epithelial markers (E-Cadherin, EpCAM negative). For cancer-associated 
fibroblast markers we recommend αSMA, FAP and FSP1/S100A4.  
 
Notes  
 
1. This procedure works exceptionally well because it is optimized for this tumour model. 
Importantly, MMTV-PyMT breast cancer cells do not grow on tissue culture plastic dishes. 
On the other hand, fibroblasts grow very well. Therefore, just by culturing your extracts in 
plastic, you are enriching for the fibroblast population and any contamination derived from 
cancer cells is avoided. However, this procedure does not work if established cancer cell 
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lines are used, as those cells are adapted to grow in plastic and will eventually overtake 
the fibroblast population. In order to prevent this, other approaches need to be designed 
(FACS sorting, use of suicide genes in cancer cells, etc). 
2. This procedure needs a well-characterized model and much familiarization with the 
different tumoral stages of its development. Therefore, it is essential that, prior to its 
application, the researcher gets familiar with it. Expert pathological evaluation is essential. 
We recommend thorough pathological analysis of multiple tumours of different ages, 
sizes, aspects and sites. This will eventually allow the researcher to confidently predict 
the stage of each tumour. Even then, retrospective pathological analysis of the tumoral 
stage of the tumours used for fibroblast isolation must always be performed. 
3. Histopathology and immunocytochemistry approaches will not be discussed in this 
protocol. Tumour progression is highly variable depending on type, tissue, mouse strain, 
etc. In order to characterise each tumoral stage, consult a pathologist to get advice about 
the best approaches, techniques and markers to clearly define each stage.  
4. Primary cells and specially fibroblasts can be maintained in culture for few passages 
before they become senescent. Senescence induces a pletora of transcriptional and 
functional changes that may affect profoundly the phenotypes under study. Therefore, if 
long term culture is desired, immortalization is necessary. Ideally, primary and 
immortalized cultures should be compared in order to check that the immortalization 
procedure has not induced any change in the phenotypes under study. For immortalizing 
mouse fibroblasts, we express the human papillomavirus “early gene” E6 that prevents 
replicative senescence by suppressing p53 activity. As a result, other “off-target” 
consequences in specific functions and signalling pathways are to be expected. For cells 
that are most affected by telomere length (e.g. human), an alternative approach is 
recommended. In those cases, cell immortalization can be achieved by expression of 
Telomerase Reverse Transcriptase protein (hTERT). This protein is inactive in most 
somatic cells, but when hTERT is exogenously expressed, the cells are able to maintain 
sufficient telomere lengths to avoid replicative senescence. Analysis of several 
telomerase-immortalized cell lines has verified that the cells maintain a stable genotype 
and retain critical phenotypic markers. 
5. Immortalization is achieved by retroviral infection of target fibroblasts. Thus, handling and 
disposal of viruses and contaminated material must be always performed in accordance 
with you institution regulations.  
6. Phoenix-ECO were originally established in Garry P. Nolan lab (Stanford University, USA) 
and are available at ATCC (Pear et al., 1993). They are a retrovirus producer line for the 
generation of helper free ecotropic retroviruses. The line is based on the 293T cell line (a 
human embryonic kidney line transformed with adenovirus E1a and carrying a 
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temperature sensitive T antigen co-selected with neomycin). This cell line is highly 
transfectable with either calcium phosphate mediated transfection or lipid-based 
transfection protocols. The line was created by placing into 293T cells constructs capable 
of producing gag-pol, and envelope protein for ecotropic viruses. Phoenix-Ampho is a 
similar cell line that instead produces amphotropic retroviruses. 
 
Recipes 
 
1.   Complete media (always to be used warm 37 °C) 
Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose with stable L-glutamine  
1% Insulin-Transferrin-Selenium solution (ITS) 
10% Fetal Bovine Serum (FBS)  
Penicillin/Streptomycin 
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